Nuvasive Accounts Payable

Nuvasive (NUVA) currently reports a accounts payable of $120M as of June 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Nuvasive's accounts payable history and peer comparisons.

Nuvasive's accounts payable changed from $0 to $120M (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nuvasive reported $120M in accounts payable as of June 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nuvasive, and consider following NUVA for alerts when major investors trade the stock.

Nuvasive is classified in the Healthcare sector. On accounts payable, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NUVA with unrelated industries.